November Healthcare M&A Deal Volume Soars

November Healthcare M&A Deal Volume Soars

The penultimate month of 2021 did not disappoint. There were 229 deals announced in November. It’s a mere five deals more than what dealmakers announced or closed in October, but the fourth quarter is shaping up to be a historic era of activity. Most of the deal activity remains focused on the lower market, highlighting the fragmentation of the market, meaning there are plenty of targets left for equity buyers and strategic investors. Aside just from a natural cooling off of the market, the only major headwind on the way is the Omicron variant, which has already hit the United States. Its been rattling public markets; Moderna and Pfizer are quickly pivoting to develop... Read More »
The Transcript: Q3 Highlights From Healthcare CEOs

The Transcript: Q3 Highlights From Healthcare CEOs

What better way to get an understanding of the healthcare market than through the CEOs of the top companies themselves? Leaders across different segments, including hospitals, telehealth, managed care, home health and more, reported strong growth and activity and have a confident outlook for the final quarter of 2021. Membership Drive “We ended the quarter with 715,000 members, 18,000 above the high end of our updated guidance from September 1, up 40% year-over-year. Similarly, our revenue also has outperformed coming in at $151 million, $3 million above the high end of our updated guidance from September, up 49% year-over-year.” – Amir Rubin, President and CEO of One Medical“We were... Read More »
November Healthcare M&A Deal Volume Soars

Q4 Kicks Off With a Bang

Here we are again. Activity in October hit 212 deals, a slight uptick compared with 207 deals announced in September, but more than 50% higher compared with October 2020. It’s an all-time record for a single month, at least for now. Some activity last month can be attributed to the typical fourth quarter surge, but fear of a capital gains tax increase and plenty of tailwinds across sectors are really pushing dealmakers to close. The chart below shows the bulk of the deal activity is concentrated in a few sectors: Physician Medical Groups, eHealth, Long-Term Care and Other Services. It has been this way for most of the year, and we don’t expect it to change in the fourth... Read More »
Industry Experts Talk Healthcare M&A Market at iiBig Virtual Roundtable

Industry Experts Talk Healthcare M&A Market at iiBig Virtual Roundtable

The editorial team at Irving Levin Associates attended the keynote panel at the iiBig 13th Annual Investment and M&A Opportunities in Healthcare Virtual Conference aptly titled “State of the Healthcare M&A Industry.” It was led by Nick Donkar, Head Deals Leader – Healthcare, PricewaterhouseCoopers, and featured John W. Jones, Jr., Partner, Troutman Pepper LLP, Burk Lindsey, Managing Director, Raymond James, Michael Ory, Managing Director, Brentwood Capital Advisors and Neil Pickett, VP and Deputy Chief of Staff Indiana University Health. The panel managed to paint an in-depth portrait of the healthcare M&A market and the forces driving such high growth this... Read More »
The Transcript: Q2 Highlights From Healthcare CEOs

The Transcript: Q2 Highlights From Healthcare CEOs

What better way to get an understanding of the healthcare market than through the CEOs of the top companies themselves? Leaders across different segments, including hospitals, telehealth, managed care, home health and more, reported strong growth and activity and have a confident outlook for the rest of the year. Health System Rebound “…we are delivering a much stronger growth trajectory on the hospital side in terms of admissions, outpatient visits, ER volumes, and surgeries. In particular, the higher acuity work that we have been focused on with general surgery, cardiovascular, ortho, neuro, etc., have been steadily progressing in key markets across the country.” – Tenet Healthcare Corp.... Read More »
The Transcript: Q3 Highlights From Healthcare CEOs

A Conversation With M&A Healthcare Advisors, a Newly Launched Boutique Advisory Firm Focused on Healthcare M&A

The healthcare editorial team at Irving Levin Associates sat down with industry veterans Mike Moran and Andre Ulloa to discuss the launch of their new advisory firm, M&A Healthcare Advisors (MAHA), and the state of the healthcare M&A market. MAHA aims to transform the M&A experience for lower-middle market healthcare business owners by providing highly accessible, transparent and experience-driven seller-representation services throughout the entire sale process.  What motivated you to launch the new firm?Andre: We saw a huge void when it came to lower-middle market seller representation in the healthcare industry. These smaller healthcare agencies are often... Read More »